Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Monitoring the response to primary medical therapy for breast cancer using three- dimensional time-resolved optical mammography.

Enfield LC, Cantanhede G, Westbroek D, Douek M, Purushotham AD, Hebden JC, Gibson AP.

Technol Cancer Res Treat. 2011 Dec;10(6):533-47.

PMID:
22066594
2.

Monitoring the response to neoadjuvant hormone therapy for locally advanced breast cancer using three-dimensional time-resolved optical mammography.

Enfield L, Cantanhede G, Douek M, Ramalingam V, Purushotham A, Hebden J, Gibson A.

J Biomed Opt. 2013 May;18(5):56012. doi: 10.1117/1.JBO.18.5.056012.

PMID:
23698285
3.

Functional imaging using diffuse optical spectroscopy of neoadjuvant chemotherapy response in women with locally advanced breast cancer.

Soliman H, Gunasekara A, Rycroft M, Zubovits J, Dent R, Spayne J, Yaffe MJ, Czarnota GJ.

Clin Cancer Res. 2010 May 1;16(9):2605-14. doi: 10.1158/1078-0432.CCR-09-1510. Epub 2010 Apr 20.

4.

Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI.

Choe R, Corlu A, Lee K, Durduran T, Konecky SD, Grosicka-Koptyra M, Arridge SR, Czerniecki BJ, Fraker DL, DeMichele A, Chance B, Rosen MA, Yodh AG.

Med Phys. 2005 Apr;32(4):1128-39.

PMID:
15895597
5.

Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy.

Pickles MD, Lowry M, Manton DJ, Gibbs P, Turnbull LW.

Breast Cancer Res Treat. 2005 May;91(1):1-10.

PMID:
15868426
6.

Pre-treatment haemoglobin levels and the prediction of response to neoadjuvant chemotherapy in breast cancer.

Beresford MJ, Burcombe R, Ah-See ML, Stott D, Makris A.

Clin Oncol (R Coll Radiol). 2006 Aug;18(6):453-8.

PMID:
16909968
8.

Three-dimensional time-resolved optical mammography of the uncompressed breast.

Enfield LC, Gibson AP, Everdell NL, Delpy DT, Schweiger M, Arridge SR, Richardson C, Keshtgar M, Douek M, Hebden JC.

Appl Opt. 2007 Jun 10;46(17):3628-38.

PMID:
17514325
9.

Optical tomography of breast cancer-monitoring response to primary medical therapy.

Enfield LC, Gibson AP, Hebden JC, Douek M.

Target Oncol. 2009 Sep;4(3):219-33. doi: 10.1007/s11523-009-0115-z. Epub 2009 Sep 24. Review.

PMID:
19777322
10.

Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer: a phase II study.

Sarid D, Ron IG, Sperber F, Stadler Y, Kahan P, Kovner F, Ben-Yosef R, Marmor S, Grinberg Y, Maimon N, Weinstein J, Yaal-Hahoshen N.

Clin Drug Investig. 2006;26(12):691-701.

PMID:
17274676
11.

Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging.

Abraham DC, Jones RC, Jones SE, Cheek JH, Peters GN, Knox SM, Grant MD, Hampe DW, Savino DA, Harms SE.

Cancer. 1996 Jul 1;78(1):91-100.

12.
13.

[Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].

Lerouge D, Touboul E, Lefranc JP, Genestie C, Moureau-Zabotto L, Blondon J.

Cancer Radiother. 2004 Jun;8(3):155-67. French.

PMID:
15217583
14.

Time-domain scanning optical mammography: II. Optical properties and tissue parameters of 87 carcinomas.

Grosenick D, Wabnitz H, Moesta KT, Mucke J, Schlag PM, Rinneberg H.

Phys Med Biol. 2005 Jun 7;50(11):2451-68. Epub 2005 May 18.

PMID:
15901948
15.

Optical mammography using diffuse optical spectroscopy for monitoring tumor response to neoadjuvant chemotherapy in women with locally advanced breast cancer.

Schaafsma BE, van de Giessen M, Charehbili A, Smit VT, Kroep JR, Lelieveldt BP, Liefers GJ, Chan A, Löwik CW, Dijkstra J, van de Velde CJ, Wasser MN, Vahrmeijer AL.

Clin Cancer Res. 2015 Feb 1;21(3):577-84. doi: 10.1158/1078-0432.CCR-14-0736. Epub 2014 Dec 3.

16.

Functional imaging of neoadjuvant chemotherapy response in women with locally advanced breast cancer using diffuse optical spectroscopy.

Soliman H, Yaffe MJ, Czarnota GJ.

Conf Proc IEEE Eng Med Biol Soc. 2009;2009:3244-6. doi: 10.1109/IEMBS.2009.5333532.

PMID:
19964289
17.

Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.

Gajdos C, Tartter PI, Estabrook A, Gistrak MA, Jaffer S, Bleiweiss IJ.

J Surg Oncol. 2002 May;80(1):4-11.

PMID:
11967899
18.

Accuracy of clinical examination, digital mammogram, ultrasound, and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer patients.

Croshaw R, Shapiro-Wright H, Svensson E, Erb K, Julian T.

Ann Surg Oncol. 2011 Oct;18(11):3160-3. doi: 10.1245/s10434-011-1919-5. Epub 2011 Sep 27.

PMID:
21947594
19.

Noninvasive monitoring of breast cancer during neoadjuvant chemotherapy using optical tomography with ultrasound localization.

Zhu Q, Tannenbaum S, Hegde P, Kane M, Xu C, Kurtzman SH.

Neoplasia. 2008 Oct;10(10):1028-40.

20.

Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy.

Londero V, Bazzocchi M, Del Frate C, Puglisi F, Di Loreto C, Francescutti G, Zuiani C.

Eur Radiol. 2004 Aug;14(8):1371-9. Epub 2004 Feb 18.

PMID:
14986052
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk